Graham Capital Management »

Revance Therapeutics shares owned by Graham Capital Management

Quarter-by-quarter ownership of Revance Therapeutics shares owned by Graham Capital Management from 13F filings

Historical chart of Graham Capital Management investment in Revance Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Revance Therapeutics held by Graham Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Revance Therapeutics by Graham Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $24M 32M 0.76
2023-09-30 $26M 32M 0.80
2023-06-30 $20M 18M 1.06

More positions owned by Graham Capital Management

Ishares Tr Russell 2000 Etf (IWM)
Microstrategy Cl A New Put Option (MSTR)
Zillow Group Note 0.750% 9/0 (Principal)
Microstrategy Note 0.750%12/1 (Principal)
Permian Resources Corp Note 3.250% 4/0 (Principal)
Peabody Engr Corp Note 3.250% 3/0 (Principal)
Tilray Brands Note 5.200% 6/1 (Principal)
Bridgebio Pharma Note 2.500% 3/1 (Principal)
Transocean Deb 4.000%12/1 (Principal)
Bill Holdings Note 12/0 (Principal)
Opko Health Note 4.500% 2/1 (Principal)
Bloom Energy Corp Note 2.500% 8/1 (Principal)
Maxeon Solar Technologies Lt SHS Call Option (MAXN)
Maxeon Solar Technologies Lt Note 6.500% 7/1 (Principal)
Zscaler Note 0.125% 7/0 (Principal)

View all positions for Graham Capital Management

Top funds holding Revance Therapeutics

Franklin Resources
D. E. Shaw & Co
Graham Capital Management
Aviva
Highbridge Capital Management
SSI Investment Management
Calamos Advisors
Amundi
Credit Suisse
CSS
Citigroup
Central Pacific Bank - Trust Division
First Hawaiian Bank
Context Capital Management
William Blair $ Company

View all funds holding Revance Therapeutics